Vertex seeks small molecules for RNA in deal with Ribometrix

In Vertex’s latest deal in its recent flurry of M&A activity, the big biotech has partnered with Ribometrix to discover and develop up to three RNA-targeted small molecule programs.

Founded in 2015, Durham, N.C.-based Ribometrix Inc.

Read the full 357 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE